Autocrine Transforming Growth Factor β Stimulation of Extracellular Matrix Production by Fibroblasts from Fibrotic Human Gingiva

Journal of Periodontology

Volumn 69, Issue 6, 1998, Pages 609-619

  Tipton, David A ^a   Dabbous, Mustafa Kh ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Department of Biochemistry ^*

Author keywords

Collagen; Extracellular matrix; Fibroblasts; Fibromatosis, gingival; Fibronectin; Growth factor, transforming

Indexed keywords

ANTIBODY; COLLAGEN; DIAGNOSTIC AGENT; FIBRONECTIN; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; AUTOCRINE EFFECT; BIOSYNTHESIS; CASE CONTROL STUDY; CELL CULTURE; CELL DIVISION; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; GINGIVA; GINGIVA FIBROMATOSIS; HUMAN; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADULT; ANTIBODIES; AUTOCRINE COMMUNICATION; CASE-CONTROL STUDIES; CELL DIVISION; CELLS, CULTURED; COLLAGEN; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; FIBROMATOSIS, GINGIVAL; FIBRONECTINS; GENE EXPRESSION REGULATION; GINGIVA; HUMANS; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032088397     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1998.69.6.609     Document Type: Article

References (68)

1. Jorgenson R, Cocker M. Variation in inheritance and expression of gingival fibromatosis. J Periodontol 1974;45:472-477.
2. Fletcher J. Gingival abnormalities of genetic origin: A preliminary communication with special reference to hereditary generalized gingival fibromatosis. J Dent Res 1966;45:597-612.
3. Gorlin RJ, Pindborg JJ, Cohen MM. Gingival fibromatosis and its symptoms. In: Syndromes of the Head and Neck. New York: McGraw Hill; 1976:329-336.
4. Shirasuna K, Okura M, Watatami I, Hayashido Y, Saka M, Matsuya T. Abnormal cellular property of fibroblasts from congenital gingival fibromatosis. J Oral Pathol 1989;7:381-385.
5. Seyer JS. Mediators of increased collagen synthesis in fibrosing organs. Fundam Appl Toxicol 1985;5:228-231.
6. Border WA, Ruoslahti E. Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 1992;90:1-7.
7. Raghow R. Role of transforming growth factor-β in repair and fibrosis. Chest 1991;99(Suppl.):61S-65S.
8. Tipton D, Howell K, Dabbous M. Increased proliferation, collagen, and fibronectin production by hereditary gingival fibromatosis fibroblasts. J Periodontol 1997;68:524-530.
9. Postlethwaite A, Raghow R, Stricklin G, Poppleton H, Seyer J, Kang A. Modulation of fibroblast functions by interleukin 1: Increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta. J Cell Biol 1988;106:311-318.
10. Mochan E, Armor L, Sporer R. Interleukin 1 stimulation of plasminogen activator production in cultured gingival fibroblasts. J Periodont Res 1988;23:28-32.
11. Vilcek J, Tsujimoto M, Palumbella V, Kohase M, Le J. Tumor necrosis factor: Receptor binding and mitogenic action in fibroblasts. J Cell Physiol 1987;5(Suppl.):57-61.
12. Varga J, Rosenbloom J, Jimenez S. Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 1987;247:597-604.
13. Seppa H, Grotendorst G, Seppa S, Schiffman E, Martin G. Platelet derived growth factor is chemotactic for fibroblasts. J Cell Biol 1982;92:584-588.
14. Roberts A, Sporn M, Assoian R, et al. Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci (USA) 1986;83:4167-4171.
15. Sporn M, Roberts A, Wakefield L, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 1987;105:1039-1045.
16. Ignotz R, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337-4345.
17. Raghow R, Postlethwaite A, Keski-Oja J, Moses H, Kang A. Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest 1987;79:1285-1288.
18. Penttinen R, Kobayashi S, Bornstein P. Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc Natl Acad Sci (USA) 1988;85:1105-1108.
19. Chen J, Hoshi H, McKeehan W. Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. Proc Natl Acad Sci (USA) 1987;84: 5287-5291.
20. Laiho M, Saksela O, Andreasen P, Keski-Oja J. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol 1986;103:2403-2410.
21. Edwards D, Murphy G, Reynolds J, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987;6:1899-1904.
22. Medsger TA. In: McCarthy DJ Jr, ed. Arthritis and Allied Conditions, 10th ed. Philadelphia: Lea and Febiger; 1985:994-1036.
23. Abergel KP, Chu M-L, Bauer EA, Uitto J. Regulation of collagen gene expression in cutaneous diseases with dermal fibrosis: Evidence for pretranslational control. J Invest Dermatol 1987;88:727-731.
24. Roberts A, Sporn M. In: Human Cytokines. London: Blackwell Scientific; 1992:399.
25. Lyons RM, Moses HL. Transforming growth factors and the regulation of cell proliferation. Eur J Biochem 1990;187:467-473.
26. Dernyck R, Lindquist PB, Lee A, et al. A new type of transforming growth factor-β, TGF β3. EMBO J 1988;7:3737-3743.
27. Massagué J. The transforming growth factor-β family. Ann Rev Cell Biol 1990;6:597-641.
28. Mackay SLD, Yaswen LR, Tarnuzzer RW, et al. Colon cancer cells that are not growth inhibited by TGF β lack functional type I and type II TGF β receptors. Ann Surg 1995;221:767-777.
29. Hoyt D, Lazo J. Alteration in pulmonary mRNA encoding procollagens, fibronectin. and transforming growth factor βprecede bleomycin-induced pulmonary fibrosis in mice. J Pharm Exp Ther 1988; 246:765-771.
30. Armendariz-Borunda J, Seyer J, Kang A, Raghow R. Regulation of TGF β gene expression in rat liver intoxicated with carbon tetrachloride. FASEB J 1990;4:215-221.
31. Roberts AB, Sporn MB. The transforming growth factor-betas: Past, present, and future. Ann NY Acad Sci 1990;593:1-6.
32. Jennings MT, Maciunas RJ, Carver R, Bascom C, Juneau P, Moses HL. TGF-β1 and TGF-β2 are potential growth regulators for low-grade and malignant gliomas in vitro: Evidence in support of autocrine hypothesis. Int J Cancer 1991;49:129-139.
33. Jachimczak P, Hessdörfer B, Fabel-Schulte K, et al. Transforming growth factor-β-mediated autocrine growth regulation of gliomas as detected with pnosphorothioate antisense oligonucleotides. Int J Cancer 1996;65:332-337.
34. 1, in human colon carcinoma FET cells. J Biol Chem 1995;270:14154-14159.
35. Tipton DA, Pabst MJ, Dabbous MKh. Interleukin-1β- and tumor necrosis factor α-independent monocyte stimulation of fibroblast collagenase activity. J Cell Biochem 1990;44:253-264.
36. Roberts AB. Froli C, Anzano M, Assoian RK, Sporn MB. Purification of type β transforming growth factors from non-neoplastic tissues. Methods for preparation of media. Supplements and substrata from serum-free animal culture. In: Barnes DW, Sirbasku DA, Stao GH, eds. Cell Culture Methods for Molecular Cell Biology. New York: Alan R. Liss Inc.; 1984:181-194.
37. Godden J, Porteus C, George W, Kerr D. Bioassay of transforming growth factor-β activity in acidic protein extracts from primary breast cancer specimens. Anticancer Res 1993;13:427-432.
38. Odekon L, Blasi F, Rifkin D. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF β to TGF β. J Cell Physiol 1994;158:398-407.
39. Lowry O, Rosebrough N, Fair A, Randall R. Protein measurement with the folin-phenol reagent. J Biol Chem 1951;193:265-275.
40. Tipton DA, Braxton SD, Dabbous MKh. Effects of a bleaching agent on human gingival fibroblasts. J Periodontol 1995;66:7-13.
41. Lawrence DA, Pircher R, Kryceve-Martinerie C, Julien P. Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol 1984;121:184-188.
42. Needleman BW, Choi J, Burrows-Mezu A, Fontana JA. Secretion and binding of transforming growth factor β by scleroderma and normal dermal fibroblasts. Arthritis Rheum 1990;33:650-656.
43. Ko SD, Page RC, Narayanan AS. Fibroblast heterogeneity and prostaglandin regulation of subpopulations. Proc Natl Acad Sci (USA) 1977;74:3429-3432.
44. Hassell T, Stanek E. Evidence that healthy human gingiva contains functionally heterogeneous fibroblast subpopulations. Arch Oral Biol 1983;28:617-625.
45. Bordin S, Page R, Narayanan A. Heterogeneity of normal human diploid fibroblasts: Isolation and characterization of one phenotype. Science 1984;223:171-173.
46. Tipton DA, Stricklin GP, Dabbous MKh. Fibroblast heterogeneity in collagenolytic response to cyclosporine. J Cell Biochem 1991;46: 152-165.
47. Vuorio T, Kähäri V-M, Black C, Vuorio E. Expression of osteonectin, decorin, and transforming growth factor-β1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea. J Rheumatol 1991;18:247-251.
48. Massagué J. Receptors for the TGF-β family. Cell 1992;69:1067-1070.
49. Tipton DA, Dabbous MKh. Expression of TGFβ receptors on normal and fibrotic fibroblasts. J Dent Res 1997;76(Spec. Issue):441 (Abstr. 3424).
50. Lawrence DA, Pircher R, Julien P. Conversion of high molecular weight latent TGF-β from chicken embryo fibroblasts into a low molecular weight active TGF-β under acidic conditions. Biochem Biophys Res Commun 1985;133:1026-1034.
51. Glick AB, Flanders KC, Danielpour D, Yuspa SH, Sporn MB. Retinoic acid induces transforming growth factor-β2 in cultured keratinocytes and mouse epidermis. Cell Reg 1989;1:87-97.
52. Arteaga CL, Coffey RJ, Dugger TC, McCutchen CM, Moses HL, Lyons R. Growth stimulation of human breast cancer cells with antitransforming growth factor β antibodies: Evidence for negative autocrine regulation by transforming growth factor β. Cell Growth Differ 1990:1:367-374.
53. 1 in human colon carcinoma FET cells. J Biol Chem 1995;270:14154-14159.
54. Rasoamanantena P, Thweatt R, Cabat-Robert J, Goldstein S. Altered regulation of fibronectin gene expression in Werner syndrome fibroblasts. Exp Cell Res 1994;213:121-127.
55. Mann DM, McKeown-Longos PJ, Millis AJT. Binding of soluble fibronectin and its subsequent incorporation into the ECM by early and late passage human skin fibroblasts. J Biol Chem 1988;263: 2756-2760.
56. Atkinson PR, Weidman ER, Blaumick B, Bala RM. Release of somatomedin-like activity by cultured Wi-38 human fibroblasts. Endocrinology 1980;108:2006-2012.
57. Gillery P, Lepere A, Maquar F-X, Borel J-P. Insulin-like growth factor (IGF-1) stimulates protein synthesis and collagen gene expression in monolayer or lattice cultures of fibroblasts. J Cell Physiol 1992;152:389-396.
58. Keating MT, Williams LT. Autocrine stimulation of intracellular PDGF receptors in v-sis transformed cells. Science 1988;239:914-916.
59. Sporn MB, Roberts AB. Autocrine secretion - 10 years later. Ann Intern Med 1992;117:408-414.
60. Wang Q, Marini JC. Antisense oligonucleotides selectively suppress expression of the mutant alpha 2(1) collagen allele in type IV osteogenesis imperfecta fibroblasts. A molecular approach to therapeutics of dominant negative disorders. J Clin Invest 1996;97:448-454.
61. Laptev AV, Lu Z, Colige A. Prockop DJ. Specific inhibition of expression of a human collagen gene (COL1A1) with modified antisense oligonucleotides. The most effective target sites are clustered in double-stranded regions of the predicted secondary structure for the mRNA. Biochemistry 1994;33:11033-11039.
62. Edwards DR, Murphy G. Reynolds JJ, et al. Transforming growth factor β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987;6:1899-1904.
63. Tipton DA, Dabbous MKh. Activation of hereditary gingival fibromatosis fibroblasts and connective tissue accumulation. J Dent Res 1992;71(Spec. Issue): 155 (Abstr. 398).
64. Ziyadeh FN, Sharma K, Ericksen M, Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 1994;93:536-542.
65. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990;346:371-374.
66. Tipton D, Dabbous M. Effect of TGF β on proliferation and fibronectin production by fibroblasts from normal and fibrotic gingiva. Molec Biol Cell 1996;7(Suppl.):188( Abstr. 1094).
67. Ross R. The pathogenesis of atherosclerosis: An update. N Engl J Med 1986;314:488-500.
68. Khalil N, O'Conner RN, Unruh HW, et al. Increased production and immunohistochemical localization of transforming growth factor-β (TGF-β) in idiopathic pulmonary fibrosis. Am J Respir Cell Molec Biol 1991;5:155-162.